Ex-FDA Executive Warns Big Pharma is Banning Health Supplements | Daniel Fabricant
The guest, a former FDA Director of Dietary Supplement Programs, argues that the FDA is prioritizing pharmaceutical intellectual property protection over public access to safe supplements, citing the regulatory battles osummaryFDA Funding Bias: Approximately 72-73% of the FDA's budget comes from pharmaceutical user fees, creating a conflict of interest where the agency prioritizes protecting drug patents over regulating food and supplements.takeawayRegulatory Strategy Against Supplements: The FDA is using the 'drug exclusion criterion' (IND history) to block natural compounds like NAC and NMN from the supplement market, even when they have decades of safe use as fotakeaway
